Notice Information
Notice Title
NP47924 Cytokine Modulators
Notice Description
Supply of Cytokine Modulators to NHS Scotland.
Lot Information
Etanercept
Supply of Etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Infliximab IVSupply of Infliximab IV to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Infliximab SCSupply of Infliximab SC to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Methotrexate syringes (25mg/1 ml concentration)Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Methotrexate pens (25mg/1ml concentration)Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Methotrexate pens (50mg/1 ml concentration)Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Methotrexate syringes (50mg/1ml concentration)Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-04b34f
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/010054-2025
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- £22,963,164 £10M-£100M
- Awards Value
- Not specified
- Contracts Value
- £55,943,000 £10M-£100M
Notice Dates
- Publication Date
- 19 Mar 202511 months ago
- Submission Deadline
- 2 Dec 2024Expired
- Future Notice Date
- Not specified
- Award Date
- 29 Jan 20251 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Contact Name
- Stephanie McNiven
- Contact Email
- stephanie.mcniven2@nhs.scot
- Contact Phone
- +44 1312756000
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH12 9EB
- Post Town
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice URLs
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-04b34f-2025-03-19T09:15:55Z",
"date": "2025-03-19T09:15:55Z",
"ocid": "ocds-h6vhtk-04b34f",
"description": "The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the twenty four (24) month contract duration and the twenty four (24) month extension period of the framework agreement. (SC Ref:793130)",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-04b34f",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "NP47924 Cytokine Modulators",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
},
"mainProcurementCategory": "goods",
"description": "Supply of Cytokine Modulators to NHS Scotland.",
"lots": [
{
"id": "1",
"title": "Etanercept",
"description": "Supply of Etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 11337834,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "2",
"title": "Infliximab IV",
"description": "Supply of Infliximab IV to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 5584117,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "3",
"title": "Infliximab SC",
"description": "Supply of Infliximab SC to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 1364625,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "4",
"title": "Methotrexate syringes (25mg/1 ml concentration)",
"description": "Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 57674,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "5",
"title": "Methotrexate pens (25mg/1ml concentration)",
"description": "Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 57473,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "6",
"title": "Methotrexate pens (50mg/1 ml concentration)",
"description": "Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 4459687,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
},
{
"id": "7",
"title": "Methotrexate syringes (50mg/1ml concentration)",
"description": "Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 101754,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "2"
},
{
"id": "3",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "3"
},
{
"id": "4",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "4"
},
{
"id": "5",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "5"
},
{
"id": "6",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "6"
},
{
"id": "7",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "7"
}
],
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"selectionCriteria": {
"criteria": [
{
"type": "technical",
"description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.",
"minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products. (d) A completed copy of the Bidder Climate Change Plan Template, including planned projects and actions to reduce the bidder's carbon emissions should be provided in the Qualification Envelope of the ITT under Environmental Management Criteria. This does not need to contain calculated carbon emissions.",
"appliesTo": [
"supplier"
]
}
]
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"techniques": {
"hasFrameworkAgreement": true,
"frameworkAgreement": {
"maximumParticipants": 8
}
},
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2024-12-02T12:00:00Z"
},
"submissionTerms": {
"languages": [
"en"
]
},
"awardPeriod": {
"startDate": "2024-12-02T12:00:00Z"
},
"bidOpening": {
"date": "2024-12-02T12:00:00Z"
},
"hasRecurrence": false,
"contractTerms": {
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed",
"hasElectronicPayment": true
},
"reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a 'standstill period' of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages."
},
"parties": [
{
"id": "GB-FTS-115937",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"address": {
"streetAddress": "1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Stephanie McNiven",
"telephone": "+44 1312756000",
"email": "stephanie.mcniven2@nhs.scot",
"url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html"
},
"roles": [
"buyer",
"centralPurchasingBody"
],
"details": {
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-324",
"name": "Sheriff Court House",
"identifier": {
"legalName": "Sheriff Court House"
},
"address": {
"streetAddress": "27 Chambers Street",
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 1312252525",
"email": "edinburgh@scotcourts.gov.uk"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://scotcourts.gov.uk/the-courts/sheriff-court/about-sheriff-courts"
}
},
{
"id": "GB-FTS-141106",
"name": "Biogen Idec Ltd",
"identifier": {
"legalName": "Biogen Idec Ltd"
},
"address": {
"streetAddress": "Biogen Building 5 Foundation Park, , Roxborough Way, Maidenhead, Berkshire, England,",
"locality": "Maidenhead",
"region": "UK",
"postalCode": "SL6 3UD",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-5312",
"name": "Celltrion Healthcare United Kingdom Limited",
"identifier": {
"legalName": "Celltrion Healthcare United Kingdom Limited"
},
"address": {
"streetAddress": "1-7 The Switch",
"locality": "Slough",
"region": "UK",
"postalCode": "SL1 1QP",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-4550",
"name": "Accord Healthcare Ltd",
"identifier": {
"legalName": "Accord Healthcare Ltd"
},
"address": {
"streetAddress": "Sage House, 319 Piner Road",
"locality": "North Harrow",
"region": "UK",
"postalCode": "HA1 4HF",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-141107",
"name": "Nordic Pharma Ltd",
"identifier": {
"legalName": "Nordic Pharma Ltd"
},
"address": {
"streetAddress": "Abbey House, 1650 Arlington Business Park, Theale",
"locality": "Reading",
"region": "UK",
"postalCode": "RG7 4SA",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-95765",
"name": "Sandoz",
"identifier": {
"legalName": "Sandoz"
},
"address": {
"streetAddress": "Park View, Riverside Way, Watchmoor Park",
"locality": "Camberley, Surrey",
"region": "UK",
"postalCode": "GU15 3YL",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-57454",
"name": "Pfizer Ltd",
"identifier": {
"legalName": "Pfizer Ltd"
},
"address": {
"streetAddress": "Walton Oaks, Dorking Road",
"locality": "Tadworth",
"region": "UK",
"postalCode": "KT20 7NS",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-107241",
"name": "Janssen Cilag Limited",
"identifier": {
"legalName": "Janssen Cilag Limited"
},
"address": {
"streetAddress": "50-100, Holmers Farm Way",
"locality": "High Wycombe",
"region": "UK",
"postalCode": "HP12 4EG",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-4558",
"name": "Sandoz Ltd",
"identifier": {
"legalName": "Sandoz Ltd"
},
"address": {
"streetAddress": "Frimley Business Park, Frimley",
"locality": "Camberley",
"region": "UK",
"postalCode": "GU16 7SR",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-4551",
"name": "medac Pharma LLP",
"identifier": {
"legalName": "medac Pharma LLP"
},
"address": {
"streetAddress": "Scion House, Innovation Park",
"locality": "Stirling",
"region": "UK",
"postalCode": "FK9 4NF",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
}
],
"buyer": {
"id": "GB-FTS-115937",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000781799"
}
],
"language": "en",
"awards": [
{
"id": "010054-2025-1",
"relatedLots": [
"1"
],
"title": "Etanercept",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-141106",
"name": "Biogen Idec Ltd"
},
{
"id": "GB-FTS-95765",
"name": "Sandoz"
},
{
"id": "GB-FTS-57454",
"name": "Pfizer Ltd"
}
]
},
{
"id": "010054-2025-2",
"relatedLots": [
"2"
],
"title": "Infliximab IV",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-5312",
"name": "Celltrion Healthcare United Kingdom Limited"
},
{
"id": "GB-FTS-107241",
"name": "Janssen Cilag Limited"
},
{
"id": "GB-FTS-141106",
"name": "Biogen Idec Ltd"
},
{
"id": "GB-FTS-4558",
"name": "Sandoz Ltd"
}
]
},
{
"id": "010054-2025-3",
"relatedLots": [
"5"
],
"title": "Methotrexate pens (25mg/1ml concentration)",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4550",
"name": "Accord Healthcare Ltd"
},
{
"id": "GB-FTS-4551",
"name": "medac Pharma LLP"
}
]
},
{
"id": "010054-2025-4",
"relatedLots": [
"3"
],
"title": "Infliximab SC",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-5312",
"name": "Celltrion Healthcare United Kingdom Limited"
}
]
},
{
"id": "010054-2025-5",
"relatedLots": [
"4"
],
"title": "Methotrexate syringes (25mg/1 ml concentration)",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4550",
"name": "Accord Healthcare Ltd"
}
]
},
{
"id": "010054-2025-6",
"relatedLots": [
"6"
],
"title": "Methotrexate pens (50mg/1 ml concentration)",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-141107",
"name": "Nordic Pharma Ltd"
}
]
},
{
"id": "010054-2025-7",
"relatedLots": [
"7"
],
"title": "Methotrexate syringes (50mg/1ml concentration)",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-141107",
"name": "Nordic Pharma Ltd"
}
]
}
],
"contracts": [
{
"id": "010054-2025-1",
"awardID": "010054-2025-1",
"title": "Etanercept",
"status": "active",
"value": {
"amount": 1700000,
"currency": "GBP"
},
"dateSigned": "2025-01-29T00:00:00Z"
},
{
"id": "010054-2025-2",
"awardID": "010054-2025-2",
"title": "Infliximab IV",
"status": "active",
"value": {
"amount": 44300000,
"currency": "GBP"
},
"dateSigned": "2025-01-29T00:00:00Z"
},
{
"id": "010054-2025-3",
"awardID": "010054-2025-3",
"title": "Methotrexate pens (25mg/1ml concentration)",
"status": "active",
"value": {
"amount": 5150000,
"currency": "GBP"
},
"dateSigned": "2025-01-29T00:00:00Z"
},
{
"id": "010054-2025-4",
"awardID": "010054-2025-4",
"title": "Infliximab SC",
"status": "active",
"value": {
"amount": 4200000,
"currency": "GBP"
},
"dateSigned": "2025-01-29T00:00:00Z"
},
{
"id": "010054-2025-5",
"awardID": "010054-2025-5",
"title": "Methotrexate syringes (25mg/1 ml concentration)",
"status": "active",
"value": {
"amount": 577000,
"currency": "GBP"
},
"dateSigned": "2025-01-29T00:00:00Z"
},
{
"id": "010054-2025-6",
"awardID": "010054-2025-6",
"title": "Methotrexate pens (50mg/1 ml concentration)",
"status": "active",
"value": {
"amount": 1000,
"currency": "GBP"
},
"dateSigned": "2025-01-29T00:00:00Z"
},
{
"id": "010054-2025-7",
"awardID": "010054-2025-7",
"title": "Methotrexate syringes (50mg/1ml concentration)",
"status": "active",
"value": {
"amount": 15000,
"currency": "GBP"
},
"dateSigned": "2025-01-29T00:00:00Z"
}
],
"bids": {
"statistics": [
{
"id": "36",
"measure": "bids",
"relatedLot": "1",
"value": 3
},
{
"id": "41",
"measure": "bids",
"relatedLot": "2",
"value": 4
},
{
"id": "46",
"measure": "bids",
"relatedLot": "5",
"value": 1
},
{
"id": "51",
"measure": "bids",
"relatedLot": "3",
"value": 1
},
{
"id": "56",
"measure": "bids",
"relatedLot": "4",
"value": 1
},
{
"id": "61",
"measure": "bids",
"relatedLot": "6",
"value": 1
},
{
"id": "66",
"measure": "bids",
"relatedLot": "7",
"value": 1
},
{
"id": "37",
"measure": "smeBids",
"relatedLot": "1",
"value": 0
},
{
"id": "42",
"measure": "smeBids",
"relatedLot": "2",
"value": 0
},
{
"id": "47",
"measure": "smeBids",
"relatedLot": "5",
"value": 0
},
{
"id": "52",
"measure": "smeBids",
"relatedLot": "3",
"value": 0
},
{
"id": "57",
"measure": "smeBids",
"relatedLot": "4",
"value": 0
},
{
"id": "62",
"measure": "smeBids",
"relatedLot": "6",
"value": 0
},
{
"id": "67",
"measure": "smeBids",
"relatedLot": "7",
"value": 0
},
{
"id": "38",
"measure": "foreignBidsFromEU",
"relatedLot": "1",
"value": 0
},
{
"id": "43",
"measure": "foreignBidsFromEU",
"relatedLot": "2",
"value": 0
},
{
"id": "48",
"measure": "foreignBidsFromEU",
"relatedLot": "5",
"value": 0
},
{
"id": "53",
"measure": "foreignBidsFromEU",
"relatedLot": "3",
"value": 0
},
{
"id": "58",
"measure": "foreignBidsFromEU",
"relatedLot": "4",
"value": 0
},
{
"id": "63",
"measure": "foreignBidsFromEU",
"relatedLot": "6",
"value": 0
},
{
"id": "68",
"measure": "foreignBidsFromEU",
"relatedLot": "7",
"value": 0
},
{
"id": "39",
"measure": "foreignBidsFromNonEU",
"relatedLot": "1",
"value": 0
},
{
"id": "44",
"measure": "foreignBidsFromNonEU",
"relatedLot": "2",
"value": 0
},
{
"id": "49",
"measure": "foreignBidsFromNonEU",
"relatedLot": "5",
"value": 0
},
{
"id": "54",
"measure": "foreignBidsFromNonEU",
"relatedLot": "3",
"value": 0
},
{
"id": "59",
"measure": "foreignBidsFromNonEU",
"relatedLot": "4",
"value": 0
},
{
"id": "64",
"measure": "foreignBidsFromNonEU",
"relatedLot": "6",
"value": 0
},
{
"id": "69",
"measure": "foreignBidsFromNonEU",
"relatedLot": "7",
"value": 0
},
{
"id": "40",
"measure": "electronicBids",
"relatedLot": "1",
"value": 3
},
{
"id": "45",
"measure": "electronicBids",
"relatedLot": "2",
"value": 4
},
{
"id": "50",
"measure": "electronicBids",
"relatedLot": "5",
"value": 1
},
{
"id": "55",
"measure": "electronicBids",
"relatedLot": "3",
"value": 1
},
{
"id": "60",
"measure": "electronicBids",
"relatedLot": "4",
"value": 1
},
{
"id": "65",
"measure": "electronicBids",
"relatedLot": "6",
"value": 1
},
{
"id": "70",
"measure": "electronicBids",
"relatedLot": "7",
"value": 1
}
]
}
}